In March 2012, the Supreme Court ruled, in Mayo Collaborative Servs. v. Prometheus Labs., Inc., that a patent claim on a method of determining whether a given dose of a particular type of medication was safe and effective was a “law of nature” and thus invalid. In the article, authors patent partner Robert Sachs and associate Jennifer Bush say that the Court's characterization does not withstand critical analysis.